Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Lymphokines – e.g. – interferons – interlukins – etc.
Reexamination Certificate
2006-09-19
2006-09-19
Weber, Jon (Department: 1653)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Lymphokines, e.g., interferons, interlukins, etc.
C530S324000, C530S326000, C530S327000, C530S388200, C530S402000, C424S085200, C514S012200, C514S013800, C514S014800
Reexamination Certificate
active
07109299
ABSTRACT:
Interleukin-5 receptor (IL-5R) ligands comprising amino sequences of formula TGGGDGYVX3VE X4ARCPTCK, EGYVX3VE X4ARCPTCK, EGYVX3VE X4ARCPTCR, GYVX3VE X4ARCPTCG, EGYVX3VE X4ARCPTCG, GYVX3VE X4ARCPTCR, and EGYVX3VE X4AACPTCR, and methods of using the same, are described and claimed.
REFERENCES:
patent: 3645090 (1972-02-01), Mochizuki et al.
patent: 3940475 (1976-02-01), Gross
patent: 4179337 (1979-12-01), Davis et al.
patent: 4301144 (1981-11-01), Iwashita et al.
patent: 4496689 (1985-01-01), Mitra
patent: 4612132 (1986-09-01), Wollenberg et al.
patent: 4640835 (1987-02-01), Shimizu et al.
patent: 4670417 (1987-06-01), Iwasaki et al.
patent: 4791192 (1988-12-01), Nakagawa et al.
patent: 5096704 (1992-03-01), Coffman et al.
patent: 5126352 (1992-06-01), Ganguly et al.
patent: 5143854 (1992-09-01), Pirrung et al.
patent: 5270170 (1993-12-01), Schatz et al.
patent: 5338665 (1994-08-01), Schatz et al.
patent: 5359115 (1994-10-01), Campbell et al.
patent: 5420328 (1995-05-01), Campbell
patent: 5424186 (1995-06-01), Fodor
patent: 5432018 (1995-07-01), Dower et al.
patent: 5580751 (1996-12-01), Buchardt et al.
patent: 5654276 (1997-08-01), Barrett et al.
patent: 5668110 (1997-09-01), Barrett et al.
patent: 5677280 (1997-10-01), Barrett et al.
patent: 5683983 (1997-11-01), Barrett et al.
patent: 5770358 (1998-06-01), Dower et al.
patent: 5846933 (1998-12-01), Korngold et al.
patent: 6268471 (2001-07-01), Romeo
patent: 2058003 (1991-12-01), None
patent: 2078384 (1992-09-01), None
patent: 45665 (1985-09-01), None
patent: 0 533 066 (1997-03-01), None
patent: 475746 (2000-07-01), None
patent: 9712410 (1997-06-01), None
patent: WO 90/15070 (1990-12-01), None
patent: WO 90/16184 (1993-08-01), None
patent: WO 94/28170 (1994-12-01), None
patent: WO 95/14040 (1995-05-01), None
patent: WO 95/34326 (1995-12-01), None
patent: WO 98/57991 (1998-12-01), None
patent: WO 9857979 (1998-12-01), None
England et al., PNAS, vol. 97, No. 12, pp. 6862-6867, Jun. 6, 2000.
Delgado et al., Critical Review in Therapeutic Drug Carrier Systems, vol. 9, Nos. 3, 4, pp. 249-304, 1992.
Akaji, et al.,Regioselective Double Disulfide Formation using Silylchloride-Sulfoxide System Tetrahedron Letters, (1992), 1073-1076, vol. 33, No. 8, Pergamon Press Inc., Great Britian.
Almquist, et al.,Synthesis and Biological Activity of a Ketomethylene Analogue of a tripeptide Inhibitor of Angiotensin Converting Enzyme, J. Med. Chem., (1980), 1392-1398, vol. 23, No. 12, American Chemical Society.
Barker, et al.,Cyclic RGD Peptide Analogues as Antiplatelet Antithrombotics, J. Med. Chem., (1992), 2040-2048, vol. 35, No. 11, American Chemical Society.
Bodonszky, et al.,Communications to the editor, Chem. Ind., (Sep. 17, 1966), 1597-1598, vol. 38, New Jersey.
Bundgaard, H.,Design of prodrugs. Elsevier Science Publishers, (1985), Amsterdam-New York-Oxford.
Caras et al.,Signal Peptide Secretion Directing Glycophospholipid membrane Anchor attachment, Science, (Mar. 3, 1989), 1196-1198, vol. 243, No. 4895, htp://www.jstor.com.
Chan, et al.,A 3-Amino-4-hydroxy-3-cyclobutene-1,2-dione-Containing Glutamate Analogue Exhibiting High Affinity to Excitatory Amino Acid Receptors, J. Med. Chem., (Sep. 15, 1995), 4433-4438, vol. 38, No. 22, American Chemical Society.
Chiu, et al.,Gastric Cytoprotective Properties of SCH 32651, a Novel Antiulcer Agent, Arch. Int. de Pharm. et de Thera., (1984), 128-140, vol. 270.
Cho, et al.,An Unnatural Biopolmer, Science, (Sep. 3, 1993), 1303-1305, vol. 261, No. 5126, http://www.jstor.org/.
Cwirla, et al.,Peptides on phage: A vast library of peptides for identifying ligands, Proc. Natl. Acad. Sci. USA, (Aug. 1990), 6378-6382, vol. 87.
Devos, R. et al.,Interleukin-5 and Its Receptor: A Drug Target for Eosinophilia Associated with Chronic Allergic Disease, Journal of Leukocyte Biology, (Jun., 1995), 813-819, vol. 57.
Devos, R. et al.,Recombinant soluble human interleukin-5 (hIL-5) receptor molecules, J. of Biol. Chem., (Mar. 25, 1993), 6581-6587, vol. 268, No. 9.
Dower et al.,The search for molecular diversity (2): Recombinant and synthetic randomized peptide libraries, Ann. Rep. Med. Chem., (1991), 271-280, vol. 26, Ch. 28, Academic Press Inc.
Evans, et al., Design of Nonpeptidal Ligands for a Peptide Receptor: Cholecystokinin Antagonists J. Med. Chem., (1987), 1229-1239, vol. 30, American Chemical Society.
Fattah, D., et al.,A Rapid Activation assay for Human Eosinophils Based on Adhesion to Immobilized ICAM-1, VCAM-1 and 1gG, Cytokine, (Mar., 1996), 248-259, vol. 8, No. 3 Academic Press Limited.
Fauchere,Elements for the rational design of peptide drugs, J., Adv. Drug Res., (1986), 29-69, vol. 15, Academic Press Inc. London.
Fodor, et al.,Light-Directed, Spatially addressablee Parallel Chemical Synthesis, Science, (Feb. 15, 1991), 767-773, vol. 251, No. 4995, http://www.jstor.org.
Ganderton et al.,Drug Delivery to the Respiratory Tract, Book (1987), Ellis Horwood, England.
Gilman, et al.,Goodman and Gilman's: The Pharmacological Basis of Therapeutics, (8thed.), (1990), Pergamon Press Inc. New York.
Gisin, Helv. Chim. Acta., (1973), 1467, vol. 56.
Gonda,Aerosols for delivery of therapeutic and diagnostic agents to the respiratory tract, Critical reviews in Therapeutic Drug Carrier Systems, (1990), 273-313, vol. 6, Issue, 4.
Hann et al.,On the Double Bond Isotere of the Peptide Bond: Preparation of an Enkephalin Analogue, J. Chem. Soc. Perkin Trans. I., (1982), 307-314, The Royal Society of Chemistry.
Hayashida,Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony-stimulating factor (GM-CSF): Reconstitution of a high-affinity GM-CSF receptor, Proc. Natl. Acad. Sci. USA, (Dec. 1990), 9655--9659, vol. 87.
Hazzalin, et al.,Effects of the inhibition of p38/RK MAP kinase on induction of five fos and jun genes by diverse stimuli, Oncogene, (Jul. 10, 1997), 2321-2331, vol. 15, Stock press.
Holladay, et al.,Synthesis of Hydroxyethylene and ketomethyleve Dipeptide Isosteres, Tetrahedron Lett., (1983), 4401-4404, vol. 24, No. 41, Pergamon Press Ltd, Great Britain.
Honek, J.,Unnatural Amino Acids, http://www.science.uwaterloo.ca/˜jhonek/UnnaturalAA.html (2005).
Hruby,Conformational Restrictions of Biologically Active Peptides via Amino Acid side Chain Groups, Life Sci., (1982), 189-199, vol. 31, No. 3, Pergamon Press Ltd, U.S.A.
Hruby, et al.,Emerging approaches in the molecular design of receptor-selective peptide ligands: conformational, topographical and dynamic consideration, Biochem. J., (1990), 249-262, vol. 268, Great Britain.
Hudson, D., et al.,Methionine Enkephalin and isosteric analogues. Int. J. Prpt. Prot. Res., (Feb. 13, 1979), 177-185, vol. 14, Munksgaard, Copenhagen.
Jennings-White, et al.,Synthesis of Ketomethylene Analogs of Dipeptudes, Tetrahedron Lett., (1982), 2533-2534, vol. 23, No. 25, Pergamon Press Ltd, Great Britain.
Johanson, et al.,Binding Interaction of Human Interleukin 5 with its Receptors a Subunit, J. Biol. Chem., (Apr. 21, 1995), 9459-9471, vol. 270, No. 16, The American Society for biochemistry and Molecular Biology Inc., U.S.A.
Larson, “Experimental Models of Reversable Airway Obstruction”,The Lung: Scientific Foundations, Crystal, West, et al., eds., (1991), Raven Press, New York.
Lin, et al.,Expression of T Cell Antigen Receptor Heterodimers in a Liquid- Linked Form. Science, (Aug. 10, 1990), 677-679, vol. 249, No. 4969, http://www.jstor.com.
Lopez, et al.,Recombinant human Interleukin 5 is a selective activator of human Eosinophil functionJ. Exp. Med., (Jan. 1988), 219-224, vol. 167, The Rockerfeller University Press.
March,Advanced Organic Chemistry, Encyclopedia, (1985), 1052-1061, New York, John Wiley & Sons. 3rded.
Mark, et al.,Encyclopedia of Chemical Technology, Book, (1980), New York, John Wiley & Sons, vol. 1-24, 3rdEdition.
Martens, et al.,A Generic Particle-Based Nonradioactive Homogeneous Multiplex Method for High-Throughput Screening Using Microvolume Fluorimetry, Anal. Biochem., (1999), 20-31, vol. 273, Academic Press.
McKinnon, et al.,An Interleukin 5 Mutant Distinguishes between Two Functional Responses in Hum
Balu Palani
England Bruce
Yin Qun
Affymax, Inc.
Biotechnology Law Group
Mohamed Abdel A.
Weber Jon
LandOfFree
Peptides and compounds that bind to the IL-5 receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptides and compounds that bind to the IL-5 receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides and compounds that bind to the IL-5 receptor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3568452